A carregar...
Quantifying the value of orally delivered biologic therapies: A cost-effectiveness analysis of oral semaglutide
Oral semaglutide, currently in phase three clinical trials, represents the first case of an oral biologic medication for type 2 diabetes in the form of a daily capsule. It provides similar efficacy compared to its weekly injection counterpart, but it demands a dose 280 times as high and requires mor...
Na minha lista:
| Publicado no: | J Pharm Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708477/ https://ncbi.nlm.nih.gov/pubmed/31034907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2019.04.022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|